753
Views
5
CrossRef citations to date
0
Altmetric
LETTER

Botulinum toxin in aesthetic applications: ‘How often misused words generate misleading thoughts’

(Response to: De Boulle K. Patient satisfaction with different botulinum toxin type A formulations in the treatment of moderate to severe upper facial rhytids. J Cosmet Laser Ther. 2008;10:87–92)

&
Pages 178-179 | Received 17 Sep 2008, Accepted 16 Feb 2009, Published online: 01 Sep 2009

References

  • Carruthers A, Carruthers J. Long‐term safety review of subjects treated with botulinum toxin type A (BoNT/A) for cosmetic use. Presented at the 5th International Conference on Basic and Therapeutic Aspects of Botulinum and Tetanus Toxins, Denver June 23–25 2005Poster P03
  • Rzany B, Dill‐Müller D, Grablowitz D, Heckmann M. Caird D on behalf of the German‐Austrian Retrospective Study Group. Repeated Botulinum Toxin A injections for the treatment of lines in the upper face: a retrospective study of 4103 treatments in 945 patients. Dermatol Surg. 2007;33(s1):S18–25.
  • Krack P, Deuschl G, Benecke R, Ceballos‐Baumann AO, Marion M‐H, Oertel WH, et al. Dose standardisation of botulinum toxin. Mov Disord. 1998;13:749–53.
  • Pickett A, Dodd S, Rzany B. Confusion about diffusion and the art of misinterpreting data when comparing different botulinum toxins used in aesthetic applications. J Cosmet Laser Ther. 2008;10:181–3.
  • Rzany B, Nast A. Head‐to‐head studies of botulinum toxin A in aesthetic medicine: which evidence is good enough?. J Am Acad Dermatol. 2007;56:1066–7.
  • De Maio M, Rzany B. Botulinum toxin in aesthetic medicine. Heidelberg: Springer; 2007.
  • Pickett A, Caird D. Comparison of type A botulinum toxin products in clinical use. J Clin Pharm Therapeut. 2008;33:327–8.
  • De Boulle K. Patient satisfaction with different botulinum toxin type A formulations in the treatment of moderate to severe upper facial rhytids. J Cosmet Laser Ther. 2008;10:87–92.
  • Williams H, Naldi L, Bigby M, Herxheimer A, Diepgen T, Rzany B. Evidence‐based dermatology 2nd edn.Blackwell BMJ BooksLondon2008
  • Fick A, Ann Physik. 1855;23:59 as cited by Bloomfield VA. Survey of biomolecular hydrodynamics. In:Schuster TM, editor.Biophysics textbook on-line (BTOL) - Volume: Separations and hydrodynamics2000. 116
  • Pickett A. Dysport®: Pharmacological properties and factors that influence toxin action. Presented at the 5th International Conference on Basic and Therapeutic Aspects of Botulinum and Tetanus Toxins (Toxins 2008);, Baveno, Italy 12–15 July 2008.
  • Pickett A. Diffusion of botulinum toxin in vivo is not related to the size of the toxin complex. Presented at the 5th International Conference on Basic and Therapeutic Aspects of Botulinum and Tetanus Toxins (Toxins 2008);Baveno, ItalyJuly12–152008, Poster P3.28
  • Trinidade de Almeida AR, Marques E, de Almeida J, Cunha T, Boraso R. Pilot study comparing the diffusion of two formulations of botulinum toxin type A in patients with forehead hyperhidrosis. Dermatol Surg. 2007;33:S37–43.
  • Hexsel D, Dal'Forno T, Hexsel C, do Prado DZ, Lima MM. A randomized pilot study comparing the action halos of two commercial preparations of botulinum toxin type A. Dermatol Surg. 2007;34:1–8.
  • Karsai S, Raulin C. Do different formulations of botulinum toxin type A really have different migration characteristics?. J Cosmet Dermatol. 2008;7:230.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.